Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems.
The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy.
Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.
At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.
Age ≥ 18 years at study entry.
Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy.
Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
Patient affiliated to a Social Security system in France.
Pregnant or lactating women.
Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol.
Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Single group
Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
Other interventionEach patient included will have a video-assisted remote speech therapy consultation with a private speech therapist (near the patient's home) and the expert speech therapist of IUCT-O center. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.
The rate of patients for whom tele-therapy will be considered successful.
The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation.
Click on the lead sponsor to view all of their trials.
